Multicenter trial
Multicenter trial is a type of clinical trial that is conducted at more than one medical center or clinic. These trials are often used in the field of medicine and pharmacology to test the safety and efficacy of new drugs or medical devices.
Overview[edit | edit source]
Multicenter trials are designed to provide more data than a single-center trial. They involve multiple, geographically dispersed locations that all follow the same protocol for the trial. This allows for a larger number of participants, increased generalizability, and the ability to compare results across different populations and settings.
Design and Implementation[edit | edit source]
The design and implementation of a multicenter trial involves several key steps. First, a detailed study protocol is developed, outlining the objectives, design, methodology, statistical considerations, and organization of the trial. This protocol is then reviewed and approved by an ethics committee or institutional review board at each participating center.
Once the protocol is approved, patient recruitment begins. Participants are typically randomized into different groups, such as a treatment group that receives the experimental drug or device, and a control group that receives a placebo or standard treatment.
Data from the trial is collected and analyzed by a data coordinating center. This center is responsible for ensuring data quality and integrity, and for analyzing the results of the trial.
Advantages and Disadvantages[edit | edit source]
Multicenter trials have several advantages over single-center trials. They allow for a larger number of participants, which can increase the statistical power of the study. They also allow for greater diversity in the participant population, which can increase the generalizability of the results.
However, multicenter trials also have potential disadvantages. They can be more complex and costly to manage than single-center trials. There can also be variability in the implementation of the protocol across different centers, which can introduce bias into the study.
See Also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
